Calvert Ultra-Short Investment Grade ETF (NYSEARCA:CVSB – Get Free Report) was the recipient of a large increase in short interest in October. As of October 15th, there was short interest totaling 20,419 shares, an increase of 85.4% from the September 30th total of 11,016 shares. Based on an average trading volume of 28,577 shares, the short-interest ratio is currently 0.7 days. Currently, 0.4% of the company’s shares are sold short.
Calvert Ultra-Short Investment Grade ETF Trading Down 0.0%
Calvert Ultra-Short Investment Grade ETF stock opened at $50.44 on Tuesday. Calvert Ultra-Short Investment Grade ETF has a 12-month low of $50.40 and a 12-month high of $50.96. The firm’s fifty day moving average is $50.60 and its 200 day moving average is $50.69.
Institutional Trading of Calvert Ultra-Short Investment Grade ETF
A hedge fund recently raised its position in Calvert Ultra-Short Investment Grade ETF stock. Prism Advisors Inc. boosted its stake in Calvert Ultra-Short Investment Grade ETF (NYSEARCA:CVSB – Free Report) by 13.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 19,972 shares of the company’s stock after buying an additional 2,320 shares during the quarter. Prism Advisors Inc. owned approximately 0.37% of Calvert Ultra-Short Investment Grade ETF worth $1,008,000 as of its most recent SEC filing.
Calvert Ultra-Short Investment Grade ETF Company Profile
The Calvert Ultra-Short Investment Grade ETF (CVSB) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund is an actively managed portfolio of investment grade US and foreign fixed income securities exhibiting effective management of environmental, social, and governance (ESG) risks and opportunities. The fund aims for an average portfolio duration of one year or less. CVSB was launched on Jan 30, 2023 and is managed by Calvert.
Further Reading
- Five stocks we like better than Calvert Ultra-Short Investment Grade ETF
- AST SpaceMobile’s Brazil Breakthrough Could Set the Stage for a Q3 Stock Rebound
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
Receive News & Ratings for Calvert Ultra-Short Investment Grade ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calvert Ultra-Short Investment Grade ETF and related companies with MarketBeat.com's FREE daily email newsletter.
